Nordion Inc. Stock Downgraded (NDZ)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

NEW YORK ( TheStreet) -- Nordion (NYSE: NDZ) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that revenues have generally been declining.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • Powered by its strong earnings growth of 228.16% and other important driving factors, this stock has surged by 47.62% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, our hold rating indicates that we do not recommend additional investment in this stock despite its gains in the past year.
  • NORDION INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. During the past fiscal year, NORDION INC turned its bottom line around by earning $3.83 versus -$0.47 in the prior year.
  • 48.95% is the gross profit margin for NORDION INC which we consider to be strong. Despite the high profit margin, it has decreased significantly from the same period last year. Despite the mixed results of the gross profit margin, NDZ's net profit margin of 109.61% significantly outperformed against the industry.
  • The revenue fell significantly faster than the industry average of 7.0%. Since the same quarter one year prior, revenues fell by 31.3%. The declining revenue has not hurt the company's bottom line, with increasing earnings per share.

Nordion Inc., a health science company, provides various products and services for the prevention, diagnosis, and treatment of diseases worldwide. The company operates in two segments, Sterilization Technologies and Medical Isotopes. The company has a P/E ratio of 2.5, below the S&P 500 P/E ratio of 17.7. Nordion has a market cap of $596.8 million and is part of the health care sector and health services industry. Shares are up 14.1% year to date as of the close of trading on Thursday.

You can view the full Nordion Ratings Report or get investment ideas from our investment research center.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

If you liked this article you might like

Why Nordion (NDZ) Stock Is Up Today

Why Nordion (NDZ) Stock Is Up Today

Why Nordion (NDZ) Stock Hit a One-Year High Today (Update)

Why Nordion (NDZ) Stock Hit a One-Year High Today (Update)

Nordion Inc. Stock Upgraded (NDZ)

Nordion Inc. Stock Upgraded (NDZ)

TheStreet Ratings Top 10 Rating Changes

TheStreet Ratings Top 10 Rating Changes